Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.33 USD | -5.81% | -2.69% | +175.23% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.3B |
---|---|---|---|---|---|
Net income 2024 * | -118M | Net income 2025 * | -130M | EV / Sales 2024 * | - |
Net Debt 2024 * | 293M | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
-18.1
x | Employees | 51 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.05% |
Latest transcript on Vera Therapeutics, Inc.
1 day | -5.81% | ||
1 week | -2.69% | ||
Current month | +7.14% | ||
1 month | +11.66% | ||
3 months | -2.04% | ||
6 months | +267.77% | ||
Current year | +175.23% |
Managers | Title | Age | Since |
---|---|---|---|
Marshall Fordyce
FOU | Founder | 50 | 16-04-30 |
Sean Grant
DFI | Director of Finance/CFO | 39 | 21-07-11 |
Kerry Cooper
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 16-05-31 |
Chairman | 63 | 22-05-23 | |
Patrick Enright
BRD | Director/Board Member | 62 | 20-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 42.33 | -5.81% | 644,756 |
24-05-08 | 44.94 | -0.13% | 602,893 |
24-05-07 | 45 | -1.19% | 1,183,011 |
24-05-06 | 45.54 | +4.83% | 602,028 |
24-05-03 | 43.44 | -0.14% | 884,354 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.23% | 2.3B | |
+23.37% | 47.02B | |
+49.67% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- VERA Stock